Cargando…

Identification of CDC25 as a Common Therapeutic Target for Triple-Negative Breast Cancer

CDK4/6 inhibitors are effective against cancer cells expressing the tumor suppressor RB1, but not RB1-deficient cells, posing the challenge of how to target RB1 loss. In triple-negative breast cancer (TNBC), RB1 and PTEN are frequently inactivated together with TP53. We performed kinome/phosphatase...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Jeff C., Granieri, Letizia, Shrestha, Mariusz, Wang, Dong-Yu, Vorobieva, Ioulia, Rubie, Elizabeth A., Jones, Rob, Ju, YoungJun, Pellecchia, Giovanna, Jiang, Zhe, Palmerini, Carlo A., Ben-David, Yaacov, Egan, Sean E., Woodgett, James R., Bader, Gary D., Datti, Alessandro, Zacksenhaus, Eldad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357459/ https://www.ncbi.nlm.nih.gov/pubmed/29617654 http://dx.doi.org/10.1016/j.celrep.2018.03.039

Ejemplares similares

Molecular stratification within triple-negative breast cancer subtypes
por: Wang, Dong-Yu, et al.
Publicado: (2019)

Inhibition of eEF2K synergizes with glutaminase inhibitors or 4EBP1 depletion to suppress growth of triple-negative breast cancer cells
por: Ju, YoungJun, et al.
Publicado: (2021)

Distinct shared and compartment-enriched oncogenic networks drive primary versus metastatic breast cancer
por: Jiang, Zhe, et al.
Publicado: (2023)

CDK4/6 inhibitors and the pRB-E2F1 axis suppress PVR and PD-L1 expression in triple-negative breast cancer
por: Shrestha, Mariusz, et al.
Publicado: (2023)

A subgroup of microRNAs defines PTEN-deficient, triple-negative breast cancer patients with poorest prognosis and alterations in RB1, MYC, and Wnt signaling
por: Wang, Dong-Yu, et al.
Publicado: (2019)

Thinking (Metastasis) outside the (Primary Tumor) Box
por: Jiang, Zhe, et al.
Publicado: (2023)

High-throughput screen identifies disulfiram as a potential therapeutic for triple-negative breast cancer cells: Interaction with IQ motif-containing factors
por: Robinson, Tyler JW, et al.
Publicado: (2013)

RB1 Status in Triple Negative Breast Cancer Cells Dictates Response to Radiation Treatment and Selective Therapeutic Drugs
por: Robinson, Tyler J. W., et al.
Publicado: (2013)

Stratifying the stratifiers of triple negative breast cancer
por: Wang, Dong-Yu, et al.
Publicado: (2020)

Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer
por: Wang, Sharon, et al.
Publicado: (2016)

Combined deletion of Pten and p53 in mammary epithelium accelerates triple-negative breast cancer with dependency on eEF2K
por: Liu, Jeff C, et al.
Publicado: (2014)

A Tumor initiating cell-enriched prognostic signature for HER2(+):ERα(−) breast cancer; rationale, new features, controversies and future directions
por: Liu, Jeff C., et al.
Publicado: (2013)

Progression to Metastasis of Solid Cancer
por: Zacksenhaus, Eldad, et al.
Publicado: (2021)

Targeting HER2(+) breast cancer: the TBK1/IKKε axis
por: Jiang, Zhe, et al.
Publicado: (2014)

Common and distinct features of mammary tumors driven by Pten-deletion or activating Pik3ca mutation
por: Liu, Jeff C., et al.
Publicado: (2016)

Activation of retinoblastoma protein in mammary gland leads to ductal growth suppression, precocious differentiation, and adenocarcinoma
por: Jiang, Zhe, et al.
Publicado: (2002)

The ets transcription factor Fli-1 in development, cancer and disease
por: Li, Youjun, et al.
Publicado: (2014)

Targeting an MDM2/MYC Axis to Overcome Drug Resistance in Multiple Myeloma
por: Faruq, Omar, et al.
Publicado: (2022)

Elevated PI3K signaling drives multiple Breast Cancer subtypes
por: Adams, Jessica R., et al.
Publicado: (2011)

Rescue of myogenic defects in Rb-deficient cells by inhibition of autophagy or by hypoxia-induced glycolytic shift
por: Ciavarra, Giovanni, et al.
Publicado: (2010)

The vulnerability of RB loss in breast cancer: Targeting a void in cell cycle control
por: Knudsen, Erik S., et al.
Publicado: (2018)

Hypophosphorylated pRb knock‐in mice exhibit hallmarks of aging and vitamin C‐preventable diabetes
por: Jiang, Zhe, et al.
Publicado: (2022)

Associations Between XPD Lys751Gln Polymorphism and Leukemia: A Meta-Analysis
por: Wen, Min, et al.
Publicado: (2018)

Methylation data of mouse Rb-deficient pineoblastoma
por: Chung, Philip E.D., et al.
Publicado: (2020)

High-throughput drug library screening identifies colchicine as a thyroid cancer inhibitor
por: Zhang, Le, et al.
Publicado: (2016)

FLI1 promotes protein translation via the transcriptional regulation of MKNK1 expression
por: Wang, Chunlin, et al.
Publicado: (2019)

FLI1 Induces Megakaryopoiesis Gene Expression Through WAS/WIP-Dependent and Independent Mechanisms; Implications for Wiskott-Aldrich Syndrome
por: Wang, Chunlin, et al.
Publicado: (2021)

ERK activation via A1542/3 limonoids attenuates erythroleukemia through transcriptional stimulation of cholesterol biosynthesis genes
por: Yu, Fang, et al.
Publicado: (2021)

Critical Role of the Rb Family in Myoblast Survival and Fusion
por: Ciavarra, Giovanni, et al.
Publicado: (2011)

Effect of glycogen synthase kinase-3 inactivation on mouse mammary gland development and oncogenesis
por: Dembowy, J, et al.
Publicado: (2015)

Timing is everything: Rb’s choice in islet-cell fate
por: Cai, Erica P, et al.
Publicado: (2014)

A C21-steroidal derivative suppresses T-cell lymphoma in mice by inhibiting SIRT3 via SAP18-SIN3
por: Gajendran, Babu, et al.
Publicado: (2020)

FLI1 Regulates Histamine Decarboxylase Expression to Control Inflammation Signaling and Leukemia Progression
por: Hu, Jifen, et al.
Publicado: (2023)

Conserved and specific functions of mammalian ssu72
por: St-Pierre, Benoit, et al.
Publicado: (2005)

Suppression of Her2/Neu mammary tumor development in mda-7/IL-24 transgenic mice
por: Li, You-Jun, et al.
Publicado: (2015)

UM171 cooperates with PIM1 inhibitors to restrict HSC expansion markers and suppress leukemia progression
por: Hu, Anling, et al.
Publicado: (2022)

Selective ERK1/2 agonists isolated from Melia azedarach with potent anti-leukemic activity
por: Wang, Ning, et al.
Publicado: (2019)

Lovastatin inhibits erythroleukemia progression through KLF2-mediated suppression of MAPK/ERK signaling
por: Gao, Jian, et al.
Publicado: (2023)

Agrin-Induced Acetylcholine Receptor Clustering Is Mediated by the Small Guanosine Triphosphatases Rac and Cdc42
por: Weston, Christi, et al.
Publicado: (2000)

Identification of cell proliferation, immune response and cell migration as critical pathways in a prognostic signature for HER2(+):ERα(-) breast cancer
por: Liu, Jeffrey C., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_evfkudf9018ogimln8ekpdvor7